BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

6 Months Ended

Jun. 30, 2018

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and six months ended June 30, 2018 and 2017 are as follows (dollars in thousands):

	Three Months Ended														Six Months Ended
	June 30,														June 30,
	2018							2017							2018							2017
Laser systems	$	7,920			65.2	%		$	7,961			63.1	%		$	13,623			61.4	%		$	14,690			62.6	%
Imaging systems		371			3.1	%			954			7.5	%			954			4.3	%			1,580			6.7	%
Consumables and other		2,303			18.9	%			2,051			16.3	%			4,337			19.6	%			3,743			15.9	%
Services		1,557			12.8	%			1,614			12.8	%			3,254			14.7	%			3,409			14.5	%
License fees and royalties		3			0.0	%			32			0.3	%			6			0.0	%			64			0.3	%
Total revenue	$	12,154			100.0	%		$	12,612			100.0	%		$	22,174			100.0	%		$	23,486			100.0	%